Global Veterinary Immunization Market Growth 2026-2032
The global Veterinary Immunization market size is predicted to grow from US$ 12881 million in 2025 to US$ 24059 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
In 2025, global Veterinary Immunization approximately 470,252 k doses, with an average global market price of around US$ 28 per dose. Gross margin is about 47%. The cost is 15 usd. The Production is about 500,000 k doses. Veterinary Immunizations are biological products used to prevent and control diseases in animals by stimulating an immune response, thereby enhancing the animal's resistance to pathogens. These vaccines cover poultry, livestock, companion animals, and aquaculture species, and include inactivated vaccines, live-attenuated vaccines, subunit vaccines, and nucleic acid-based vaccines. They are widely used in livestock farming, pet health management, and overall animal disease control systems.
With the global population increasing and rising demand for animal protein, the livestock, poultry, companion animal, and aquaculture sectors will continue to drive demand for animal vaccines. The diversity of animal diseases, cross-species transmission risks, and restrictions on antibiotic use make vaccines a central component of disease prevention strategies. In the future, companies will focus on innovative vaccine technologies, including genetically engineered vaccines, subunit vaccines, viral vector vaccines, mRNA vaccines, and DNA vaccines, aiming to enhance immune response, extend protection duration, and reduce side effects.
Digital and intelligent farming management will enable more precise and personalized vaccination programs. IoT, sensors, and data analytics platforms allow real-time monitoring of animal health, disease risk, and immune status, enabling scientific determination of vaccination schedules, dosages, and combination strategies. This approach improves vaccine effectiveness, reduces farming risks, and supports large-scale management for industrial farms and veterinary institutions.
Moreover, global policy support for animal health, regulatory standardization, and vaccine certification systems will encourage more companies to invest in research, development, and market expansion. Multinational and domestic firms will strengthen collaboration through technology sharing, joint R&D, supply chain integration, and regional production layout to cover more animal species and regions. As the vaccine market becomes more international and standardized, the animal health vaccine industry chain will mature, elevating global animal health management, while simultaneously driving growth in biopharmaceuticals, vaccine manufacturing equipment, and digital agriculture services.
LP Information, Inc. (LPI) ' newest research report, the ?Veterinary Immunization Industry Forecast? looks at past sales and reviews total world Veterinary Immunization sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Immunization sales for 2026 through 2032. With Veterinary Immunization sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Immunization industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Immunization landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Immunization portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Immunization market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Immunization and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Immunization.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Immunization market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Veterinary Immunization market?
What factors are driving Veterinary Immunization market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Immunization market opportunities vary by end market size?
How does Veterinary Immunization break out by Type, by Application?
In 2025, global Veterinary Immunization approximately 470,252 k doses, with an average global market price of around US$ 28 per dose. Gross margin is about 47%. The cost is 15 usd. The Production is about 500,000 k doses. Veterinary Immunizations are biological products used to prevent and control diseases in animals by stimulating an immune response, thereby enhancing the animal's resistance to pathogens. These vaccines cover poultry, livestock, companion animals, and aquaculture species, and include inactivated vaccines, live-attenuated vaccines, subunit vaccines, and nucleic acid-based vaccines. They are widely used in livestock farming, pet health management, and overall animal disease control systems.
With the global population increasing and rising demand for animal protein, the livestock, poultry, companion animal, and aquaculture sectors will continue to drive demand for animal vaccines. The diversity of animal diseases, cross-species transmission risks, and restrictions on antibiotic use make vaccines a central component of disease prevention strategies. In the future, companies will focus on innovative vaccine technologies, including genetically engineered vaccines, subunit vaccines, viral vector vaccines, mRNA vaccines, and DNA vaccines, aiming to enhance immune response, extend protection duration, and reduce side effects.
Digital and intelligent farming management will enable more precise and personalized vaccination programs. IoT, sensors, and data analytics platforms allow real-time monitoring of animal health, disease risk, and immune status, enabling scientific determination of vaccination schedules, dosages, and combination strategies. This approach improves vaccine effectiveness, reduces farming risks, and supports large-scale management for industrial farms and veterinary institutions.
Moreover, global policy support for animal health, regulatory standardization, and vaccine certification systems will encourage more companies to invest in research, development, and market expansion. Multinational and domestic firms will strengthen collaboration through technology sharing, joint R&D, supply chain integration, and regional production layout to cover more animal species and regions. As the vaccine market becomes more international and standardized, the animal health vaccine industry chain will mature, elevating global animal health management, while simultaneously driving growth in biopharmaceuticals, vaccine manufacturing equipment, and digital agriculture services.
LP Information, Inc. (LPI) ' newest research report, the ?Veterinary Immunization Industry Forecast? looks at past sales and reviews total world Veterinary Immunization sales in 2025, providing a comprehensive analysis by region and market sector of projected Veterinary Immunization sales for 2026 through 2032. With Veterinary Immunization sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Immunization industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Immunization landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Immunization portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Immunization market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Immunization and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Immunization.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Immunization market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Livestock Vaccines (pigs, cattle, sheep, etc.)
- Poultry Vaccines (chickens, ducks, geese, etc.)
- Companion Animal Vaccines (dogs, cats, etc.)
- Aquaculture Vaccines (fish, shrimp, etc.)
- Short-term (<3 months)
- Medium-term (3?12 months)
- Long-term (>12 months)
- Livestock Farms
- Poultry Farms
- Pet Clinics
- Aquaculture Farms
- Government Disease Control Agencies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim Animal Health
- Elanco
- Ceva Sant? Animale
- Virbac
- HIPRA
- MSD Animal Health
- Phibro Animal Health
- Vetoquinol
- IDT Biologika
- Hester Biosciences
- Indian Immunologicals Ltd
- Huvepharma
- Neogen Corporation
- BioNet?Asia
- KBNP Inc.
- Vaxxinova
- Guangdong Haid Group Co.,Limited
- China National Medicines Corporation Ltd.
- Harbin Pharmaceutical Group Co., Ltd.
- North China Pharmaceutical Group Corporation
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
What is the 10-year outlook for the global Veterinary Immunization market?
What factors are driving Veterinary Immunization market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Immunization market opportunities vary by end market size?
How does Veterinary Immunization break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Immunization Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Veterinary Immunization by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Veterinary Immunization by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Immunization Segment by Type
2.2.1 Livestock Vaccines (pigs, cattle, sheep, etc.)
2.2.2 Poultry Vaccines (chickens, ducks, geese, etc.)
2.2.3 Companion Animal Vaccines (dogs, cats, etc.)
2.2.4 Aquaculture Vaccines (fish, shrimp, etc.)
2.2.5 Veterinary Immunization Sales by Type
2.2.5.1 Global Veterinary Immunization Sales Market Share by Type (2021-2026)
2.2.5.2 Global Veterinary Immunization Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Veterinary Immunization Sale Price by Type (2021-2026)
2.3 Veterinary Immunization Segment by Time
2.3.1 Short-term (<3 months)
2.3.2 Medium-term (3?12 months)
2.3.3 Long-term (>12 months)
2.3.4 Veterinary Immunization Sales by Time
2.3.4.1 Global Veterinary Immunization Sales Market Share by Time (2021-2026)
2.3.4.2 Global Veterinary Immunization Revenue and Market Share by Time (2021-2026)
2.3.4.3 Global Veterinary Immunization Sale Price by Time (2021-2026)
2.4 Veterinary Immunization Segment by Application
2.4.1 Livestock Farms
2.4.2 Poultry Farms
2.4.3 Pet Clinics
2.4.4 Aquaculture Farms
2.4.5 Government Disease Control Agencies
2.4.6 Other
2.4.7 Veterinary Immunization Sales by Application
2.4.7.1 Global Veterinary Immunization Sale Market Share by Application (2021-2026)
2.4.7.2 Global Veterinary Immunization Revenue and Market Share by Application (2021-2026)
2.4.7.3 Global Veterinary Immunization Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Immunization Breakdown Data by Company
3.1.1 Global Veterinary Immunization Annual Sales by Company (2021-2026)
3.1.2 Global Veterinary Immunization Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Immunization Annual Revenue by Company (2021-2026)
3.2.1 Global Veterinary Immunization Revenue by Company (2021-2026)
3.2.2 Global Veterinary Immunization Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Immunization Sale Price by Company
3.4 Key Manufacturers Veterinary Immunization Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Immunization Product Location Distribution
3.4.2 Players Veterinary Immunization Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY IMMUNIZATION BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Immunization Market Size by Geographic Region (2021-2026)
4.1.1 Global Veterinary Immunization Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Veterinary Immunization Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Immunization Market Size by Country/Region (2021-2026)
4.2.1 Global Veterinary Immunization Annual Sales by Country/Region (2021-2026)
4.2.2 Global Veterinary Immunization Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Immunization Sales Growth
4.4 APAC Veterinary Immunization Sales Growth
4.5 Europe Veterinary Immunization Sales Growth
4.6 Middle East & Africa Veterinary Immunization Sales Growth
5 AMERICAS
5.1 Americas Veterinary Immunization Sales by Country
5.1.1 Americas Veterinary Immunization Sales by Country (2021-2026)
5.1.2 Americas Veterinary Immunization Revenue by Country (2021-2026)
5.2 Americas Veterinary Immunization Sales by Type (2021-2026)
5.3 Americas Veterinary Immunization Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Immunization Sales by Region
6.1.1 APAC Veterinary Immunization Sales by Region (2021-2026)
6.1.2 APAC Veterinary Immunization Revenue by Region (2021-2026)
6.2 APAC Veterinary Immunization Sales by Type (2021-2026)
6.3 APAC Veterinary Immunization Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Immunization by Country
7.1.1 Europe Veterinary Immunization Sales by Country (2021-2026)
7.1.2 Europe Veterinary Immunization Revenue by Country (2021-2026)
7.2 Europe Veterinary Immunization Sales by Type (2021-2026)
7.3 Europe Veterinary Immunization Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Immunization by Country
8.1.1 Middle East & Africa Veterinary Immunization Sales by Country (2021-2026)
8.1.2 Middle East & Africa Veterinary Immunization Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Immunization Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Immunization Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Immunization
10.3 Manufacturing Process Analysis of Veterinary Immunization
10.4 Industry Chain Structure of Veterinary Immunization
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Immunization Distributors
11.3 Veterinary Immunization Customer
12 WORLD FORECAST REVIEW FOR VETERINARY IMMUNIZATION BY GEOGRAPHIC REGION
12.1 Global Veterinary Immunization Market Size Forecast by Region
12.1.1 Global Veterinary Immunization Forecast by Region (2027-2032)
12.1.2 Global Veterinary Immunization Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Immunization Forecast by Type (2027-2032)
12.7 Global Veterinary Immunization Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Veterinary Immunization Product Portfolios and Specifications
13.1.3 Zoetis Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Veterinary Immunization Product Portfolios and Specifications
13.2.3 Merck Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Veterinary Immunization Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Veterinary Immunization Product Portfolios and Specifications
13.4.3 Elanco Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Ceva Sant? Animale
13.5.1 Ceva Sant? Animale Company Information
13.5.2 Ceva Sant? Animale Veterinary Immunization Product Portfolios and Specifications
13.5.3 Ceva Sant? Animale Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ceva Sant? Animale Main Business Overview
13.5.5 Ceva Sant? Animale Latest Developments
13.6 Virbac
13.6.1 Virbac Company Information
13.6.2 Virbac Veterinary Immunization Product Portfolios and Specifications
13.6.3 Virbac Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Virbac Main Business Overview
13.6.5 Virbac Latest Developments
13.7 HIPRA
13.7.1 HIPRA Company Information
13.7.2 HIPRA Veterinary Immunization Product Portfolios and Specifications
13.7.3 HIPRA Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 HIPRA Main Business Overview
13.7.5 HIPRA Latest Developments
13.8 MSD Animal Health
13.8.1 MSD Animal Health Company Information
13.8.2 MSD Animal Health Veterinary Immunization Product Portfolios and Specifications
13.8.3 MSD Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MSD Animal Health Main Business Overview
13.8.5 MSD Animal Health Latest Developments
13.9 Phibro Animal Health
13.9.1 Phibro Animal Health Company Information
13.9.2 Phibro Animal Health Veterinary Immunization Product Portfolios and Specifications
13.9.3 Phibro Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Phibro Animal Health Main Business Overview
13.9.5 Phibro Animal Health Latest Developments
13.10 Vetoquinol
13.10.1 Vetoquinol Company Information
13.10.2 Vetoquinol Veterinary Immunization Product Portfolios and Specifications
13.10.3 Vetoquinol Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Vetoquinol Main Business Overview
13.10.5 Vetoquinol Latest Developments
13.11 IDT Biologika
13.11.1 IDT Biologika Company Information
13.11.2 IDT Biologika Veterinary Immunization Product Portfolios and Specifications
13.11.3 IDT Biologika Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 IDT Biologika Main Business Overview
13.11.5 IDT Biologika Latest Developments
13.12 Hester Biosciences
13.12.1 Hester Biosciences Company Information
13.12.2 Hester Biosciences Veterinary Immunization Product Portfolios and Specifications
13.12.3 Hester Biosciences Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Hester Biosciences Main Business Overview
13.12.5 Hester Biosciences Latest Developments
13.13 Indian Immunologicals Ltd
13.13.1 Indian Immunologicals Ltd Company Information
13.13.2 Indian Immunologicals Ltd Veterinary Immunization Product Portfolios and Specifications
13.13.3 Indian Immunologicals Ltd Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Indian Immunologicals Ltd Main Business Overview
13.13.5 Indian Immunologicals Ltd Latest Developments
13.14 Huvepharma
13.14.1 Huvepharma Company Information
13.14.2 Huvepharma Veterinary Immunization Product Portfolios and Specifications
13.14.3 Huvepharma Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Huvepharma Main Business Overview
13.14.5 Huvepharma Latest Developments
13.15 Neogen Corporation
13.15.1 Neogen Corporation Company Information
13.15.2 Neogen Corporation Veterinary Immunization Product Portfolios and Specifications
13.15.3 Neogen Corporation Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Neogen Corporation Main Business Overview
13.15.5 Neogen Corporation Latest Developments
13.16 BioNet?Asia
13.16.1 BioNet?Asia Company Information
13.16.2 BioNet?Asia Veterinary Immunization Product Portfolios and Specifications
13.16.3 BioNet?Asia Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 BioNet?Asia Main Business Overview
13.16.5 BioNet?Asia Latest Developments
13.17 KBNP Inc.
13.17.1 KBNP Inc. Company Information
13.17.2 KBNP Inc. Veterinary Immunization Product Portfolios and Specifications
13.17.3 KBNP Inc. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 KBNP Inc. Main Business Overview
13.17.5 KBNP Inc. Latest Developments
13.18 Vaxxinova
13.18.1 Vaxxinova Company Information
13.18.2 Vaxxinova Veterinary Immunization Product Portfolios and Specifications
13.18.3 Vaxxinova Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Vaxxinova Main Business Overview
13.18.5 Vaxxinova Latest Developments
13.19 Guangdong Haid Group Co.,Limited
13.19.1 Guangdong Haid Group Co.,Limited Company Information
13.19.2 Guangdong Haid Group Co.,Limited Veterinary Immunization Product Portfolios and Specifications
13.19.3 Guangdong Haid Group Co.,Limited Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Guangdong Haid Group Co.,Limited Main Business Overview
13.19.5 Guangdong Haid Group Co.,Limited Latest Developments
13.20 China National Medicines Corporation Ltd.
13.20.1 China National Medicines Corporation Ltd. Company Information
13.20.2 China National Medicines Corporation Ltd. Veterinary Immunization Product Portfolios and Specifications
13.20.3 China National Medicines Corporation Ltd. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 China National Medicines Corporation Ltd. Main Business Overview
13.20.5 China National Medicines Corporation Ltd. Latest Developments
13.21 Harbin Pharmaceutical Group Co., Ltd.
13.21.1 Harbin Pharmaceutical Group Co., Ltd. Company Information
13.21.2 Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
13.21.3 Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Harbin Pharmaceutical Group Co., Ltd. Main Business Overview
13.21.5 Harbin Pharmaceutical Group Co., Ltd. Latest Developments
13.22 North China Pharmaceutical Group Corporation
13.22.1 North China Pharmaceutical Group Corporation Company Information
13.22.2 North China Pharmaceutical Group Corporation Veterinary Immunization Product Portfolios and Specifications
13.22.3 North China Pharmaceutical Group Corporation Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 North China Pharmaceutical Group Corporation Main Business Overview
13.22.5 North China Pharmaceutical Group Corporation Latest Developments
13.23 Chengdu Kanghong Pharmaceutical Group Co., Ltd.
13.23.1 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information
13.23.2 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
13.23.3 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Main Business Overview
13.23.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Immunization Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Veterinary Immunization by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Veterinary Immunization by Country/Region, 2021, 2025 & 2032
2.2 Veterinary Immunization Segment by Type
2.2.1 Livestock Vaccines (pigs, cattle, sheep, etc.)
2.2.2 Poultry Vaccines (chickens, ducks, geese, etc.)
2.2.3 Companion Animal Vaccines (dogs, cats, etc.)
2.2.4 Aquaculture Vaccines (fish, shrimp, etc.)
2.2.5 Veterinary Immunization Sales by Type
2.2.5.1 Global Veterinary Immunization Sales Market Share by Type (2021-2026)
2.2.5.2 Global Veterinary Immunization Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Veterinary Immunization Sale Price by Type (2021-2026)
2.3 Veterinary Immunization Segment by Time
2.3.1 Short-term (<3 months)
2.3.2 Medium-term (3?12 months)
2.3.3 Long-term (>12 months)
2.3.4 Veterinary Immunization Sales by Time
2.3.4.1 Global Veterinary Immunization Sales Market Share by Time (2021-2026)
2.3.4.2 Global Veterinary Immunization Revenue and Market Share by Time (2021-2026)
2.3.4.3 Global Veterinary Immunization Sale Price by Time (2021-2026)
2.4 Veterinary Immunization Segment by Application
2.4.1 Livestock Farms
2.4.2 Poultry Farms
2.4.3 Pet Clinics
2.4.4 Aquaculture Farms
2.4.5 Government Disease Control Agencies
2.4.6 Other
2.4.7 Veterinary Immunization Sales by Application
2.4.7.1 Global Veterinary Immunization Sale Market Share by Application (2021-2026)
2.4.7.2 Global Veterinary Immunization Revenue and Market Share by Application (2021-2026)
2.4.7.3 Global Veterinary Immunization Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Immunization Breakdown Data by Company
3.1.1 Global Veterinary Immunization Annual Sales by Company (2021-2026)
3.1.2 Global Veterinary Immunization Sales Market Share by Company (2021-2026)
3.2 Global Veterinary Immunization Annual Revenue by Company (2021-2026)
3.2.1 Global Veterinary Immunization Revenue by Company (2021-2026)
3.2.2 Global Veterinary Immunization Revenue Market Share by Company (2021-2026)
3.3 Global Veterinary Immunization Sale Price by Company
3.4 Key Manufacturers Veterinary Immunization Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Immunization Product Location Distribution
3.4.2 Players Veterinary Immunization Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY IMMUNIZATION BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Immunization Market Size by Geographic Region (2021-2026)
4.1.1 Global Veterinary Immunization Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Veterinary Immunization Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Veterinary Immunization Market Size by Country/Region (2021-2026)
4.2.1 Global Veterinary Immunization Annual Sales by Country/Region (2021-2026)
4.2.2 Global Veterinary Immunization Annual Revenue by Country/Region (2021-2026)
4.3 Americas Veterinary Immunization Sales Growth
4.4 APAC Veterinary Immunization Sales Growth
4.5 Europe Veterinary Immunization Sales Growth
4.6 Middle East & Africa Veterinary Immunization Sales Growth
5 AMERICAS
5.1 Americas Veterinary Immunization Sales by Country
5.1.1 Americas Veterinary Immunization Sales by Country (2021-2026)
5.1.2 Americas Veterinary Immunization Revenue by Country (2021-2026)
5.2 Americas Veterinary Immunization Sales by Type (2021-2026)
5.3 Americas Veterinary Immunization Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Immunization Sales by Region
6.1.1 APAC Veterinary Immunization Sales by Region (2021-2026)
6.1.2 APAC Veterinary Immunization Revenue by Region (2021-2026)
6.2 APAC Veterinary Immunization Sales by Type (2021-2026)
6.3 APAC Veterinary Immunization Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Immunization by Country
7.1.1 Europe Veterinary Immunization Sales by Country (2021-2026)
7.1.2 Europe Veterinary Immunization Revenue by Country (2021-2026)
7.2 Europe Veterinary Immunization Sales by Type (2021-2026)
7.3 Europe Veterinary Immunization Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Immunization by Country
8.1.1 Middle East & Africa Veterinary Immunization Sales by Country (2021-2026)
8.1.2 Middle East & Africa Veterinary Immunization Revenue by Country (2021-2026)
8.2 Middle East & Africa Veterinary Immunization Sales by Type (2021-2026)
8.3 Middle East & Africa Veterinary Immunization Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Immunization
10.3 Manufacturing Process Analysis of Veterinary Immunization
10.4 Industry Chain Structure of Veterinary Immunization
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Immunization Distributors
11.3 Veterinary Immunization Customer
12 WORLD FORECAST REVIEW FOR VETERINARY IMMUNIZATION BY GEOGRAPHIC REGION
12.1 Global Veterinary Immunization Market Size Forecast by Region
12.1.1 Global Veterinary Immunization Forecast by Region (2027-2032)
12.1.2 Global Veterinary Immunization Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Veterinary Immunization Forecast by Type (2027-2032)
12.7 Global Veterinary Immunization Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Veterinary Immunization Product Portfolios and Specifications
13.1.3 Zoetis Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Veterinary Immunization Product Portfolios and Specifications
13.2.3 Merck Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Veterinary Immunization Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Veterinary Immunization Product Portfolios and Specifications
13.4.3 Elanco Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Ceva Sant? Animale
13.5.1 Ceva Sant? Animale Company Information
13.5.2 Ceva Sant? Animale Veterinary Immunization Product Portfolios and Specifications
13.5.3 Ceva Sant? Animale Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ceva Sant? Animale Main Business Overview
13.5.5 Ceva Sant? Animale Latest Developments
13.6 Virbac
13.6.1 Virbac Company Information
13.6.2 Virbac Veterinary Immunization Product Portfolios and Specifications
13.6.3 Virbac Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Virbac Main Business Overview
13.6.5 Virbac Latest Developments
13.7 HIPRA
13.7.1 HIPRA Company Information
13.7.2 HIPRA Veterinary Immunization Product Portfolios and Specifications
13.7.3 HIPRA Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 HIPRA Main Business Overview
13.7.5 HIPRA Latest Developments
13.8 MSD Animal Health
13.8.1 MSD Animal Health Company Information
13.8.2 MSD Animal Health Veterinary Immunization Product Portfolios and Specifications
13.8.3 MSD Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MSD Animal Health Main Business Overview
13.8.5 MSD Animal Health Latest Developments
13.9 Phibro Animal Health
13.9.1 Phibro Animal Health Company Information
13.9.2 Phibro Animal Health Veterinary Immunization Product Portfolios and Specifications
13.9.3 Phibro Animal Health Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Phibro Animal Health Main Business Overview
13.9.5 Phibro Animal Health Latest Developments
13.10 Vetoquinol
13.10.1 Vetoquinol Company Information
13.10.2 Vetoquinol Veterinary Immunization Product Portfolios and Specifications
13.10.3 Vetoquinol Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Vetoquinol Main Business Overview
13.10.5 Vetoquinol Latest Developments
13.11 IDT Biologika
13.11.1 IDT Biologika Company Information
13.11.2 IDT Biologika Veterinary Immunization Product Portfolios and Specifications
13.11.3 IDT Biologika Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 IDT Biologika Main Business Overview
13.11.5 IDT Biologika Latest Developments
13.12 Hester Biosciences
13.12.1 Hester Biosciences Company Information
13.12.2 Hester Biosciences Veterinary Immunization Product Portfolios and Specifications
13.12.3 Hester Biosciences Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Hester Biosciences Main Business Overview
13.12.5 Hester Biosciences Latest Developments
13.13 Indian Immunologicals Ltd
13.13.1 Indian Immunologicals Ltd Company Information
13.13.2 Indian Immunologicals Ltd Veterinary Immunization Product Portfolios and Specifications
13.13.3 Indian Immunologicals Ltd Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Indian Immunologicals Ltd Main Business Overview
13.13.5 Indian Immunologicals Ltd Latest Developments
13.14 Huvepharma
13.14.1 Huvepharma Company Information
13.14.2 Huvepharma Veterinary Immunization Product Portfolios and Specifications
13.14.3 Huvepharma Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Huvepharma Main Business Overview
13.14.5 Huvepharma Latest Developments
13.15 Neogen Corporation
13.15.1 Neogen Corporation Company Information
13.15.2 Neogen Corporation Veterinary Immunization Product Portfolios and Specifications
13.15.3 Neogen Corporation Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Neogen Corporation Main Business Overview
13.15.5 Neogen Corporation Latest Developments
13.16 BioNet?Asia
13.16.1 BioNet?Asia Company Information
13.16.2 BioNet?Asia Veterinary Immunization Product Portfolios and Specifications
13.16.3 BioNet?Asia Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 BioNet?Asia Main Business Overview
13.16.5 BioNet?Asia Latest Developments
13.17 KBNP Inc.
13.17.1 KBNP Inc. Company Information
13.17.2 KBNP Inc. Veterinary Immunization Product Portfolios and Specifications
13.17.3 KBNP Inc. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 KBNP Inc. Main Business Overview
13.17.5 KBNP Inc. Latest Developments
13.18 Vaxxinova
13.18.1 Vaxxinova Company Information
13.18.2 Vaxxinova Veterinary Immunization Product Portfolios and Specifications
13.18.3 Vaxxinova Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Vaxxinova Main Business Overview
13.18.5 Vaxxinova Latest Developments
13.19 Guangdong Haid Group Co.,Limited
13.19.1 Guangdong Haid Group Co.,Limited Company Information
13.19.2 Guangdong Haid Group Co.,Limited Veterinary Immunization Product Portfolios and Specifications
13.19.3 Guangdong Haid Group Co.,Limited Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Guangdong Haid Group Co.,Limited Main Business Overview
13.19.5 Guangdong Haid Group Co.,Limited Latest Developments
13.20 China National Medicines Corporation Ltd.
13.20.1 China National Medicines Corporation Ltd. Company Information
13.20.2 China National Medicines Corporation Ltd. Veterinary Immunization Product Portfolios and Specifications
13.20.3 China National Medicines Corporation Ltd. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 China National Medicines Corporation Ltd. Main Business Overview
13.20.5 China National Medicines Corporation Ltd. Latest Developments
13.21 Harbin Pharmaceutical Group Co., Ltd.
13.21.1 Harbin Pharmaceutical Group Co., Ltd. Company Information
13.21.2 Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
13.21.3 Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Harbin Pharmaceutical Group Co., Ltd. Main Business Overview
13.21.5 Harbin Pharmaceutical Group Co., Ltd. Latest Developments
13.22 North China Pharmaceutical Group Corporation
13.22.1 North China Pharmaceutical Group Corporation Company Information
13.22.2 North China Pharmaceutical Group Corporation Veterinary Immunization Product Portfolios and Specifications
13.22.3 North China Pharmaceutical Group Corporation Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 North China Pharmaceutical Group Corporation Main Business Overview
13.22.5 North China Pharmaceutical Group Corporation Latest Developments
13.23 Chengdu Kanghong Pharmaceutical Group Co., Ltd.
13.23.1 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information
13.23.2 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
13.23.3 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Main Business Overview
13.23.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Immunization Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Immunization Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Livestock Vaccines (pigs, cattle, sheep, etc.)
Table 4. Major Players of Poultry Vaccines (chickens, ducks, geese, etc.)
Table 5. Major Players of Companion Animal Vaccines (dogs, cats, etc.)
Table 6. Major Players of Aquaculture Vaccines (fish, shrimp, etc.)
Table 7. Global Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 8. Global Veterinary Immunization Sales Market Share by Type (2021-2026)
Table 9. Global Veterinary Immunization Revenue by Type (2021-2026) & ($ million)
Table 10. Global Veterinary Immunization Revenue Market Share by Type (2021-2026)
Table 11. Global Veterinary Immunization Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Major Players of Short-term (<3 months)
Table 13. Major Players of Medium-term (3?12 months)
Table 14. Major Players of Long-term (>12 months)
Table 15. Global Veterinary Immunization Sales by Time (2021-2026) & (K Dose)
Table 16. Global Veterinary Immunization Sales Market Share by Time (2021-2026)
Table 17. Global Veterinary Immunization Revenue by Time (2021-2026) & ($ million)
Table 18. Global Veterinary Immunization Revenue Market Share by Time (2021-2026)
Table 19. Global Veterinary Immunization Sale Price by Time (2021-2026) & (US$/Dose)
Table 20. Global Veterinary Immunization Sale by Application (2021-2026) & (K Dose)
Table 21. Global Veterinary Immunization Sale Market Share by Application (2021-2026)
Table 22. Global Veterinary Immunization Revenue by Application (2021-2026) & ($ million)
Table 23. Global Veterinary Immunization Revenue Market Share by Application (2021-2026)
Table 24. Global Veterinary Immunization Sale Price by Application (2021-2026) & (US$/Dose)
Table 25. Global Veterinary Immunization Sales by Company (2021-2026) & (K Dose)
Table 26. Global Veterinary Immunization Sales Market Share by Company (2021-2026)
Table 27. Global Veterinary Immunization Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Veterinary Immunization Revenue Market Share by Company (2021-2026)
Table 29. Global Veterinary Immunization Sale Price by Company (2021-2026) & (US$/Dose)
Table 30. Key Manufacturers Veterinary Immunization Producing Area Distribution and Sales Area
Table 31. Players Veterinary Immunization Products Offered
Table 32. Veterinary Immunization Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Veterinary Immunization Sales by Geographic Region (2021-2026) & (K Dose)
Table 36. Global Veterinary Immunization Sales Market Share Geographic Region (2021-2026)
Table 37. Global Veterinary Immunization Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Veterinary Immunization Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Veterinary Immunization Sales by Country/Region (2021-2026) & (K Dose)
Table 40. Global Veterinary Immunization Sales Market Share by Country/Region (2021-2026)
Table 41. Global Veterinary Immunization Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Veterinary Immunization Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Veterinary Immunization Sales by Country (2021-2026) & (K Dose)
Table 44. Americas Veterinary Immunization Sales Market Share by Country (2021-2026)
Table 45. Americas Veterinary Immunization Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 47. Americas Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 48. APAC Veterinary Immunization Sales by Region (2021-2026) & (K Dose)
Table 49. APAC Veterinary Immunization Sales Market Share by Region (2021-2026)
Table 50. APAC Veterinary Immunization Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 52. APAC Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 53. Europe Veterinary Immunization Sales by Country (2021-2026) & (K Dose)
Table 54. Europe Veterinary Immunization Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 56. Europe Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 57. Middle East & Africa Veterinary Immunization Sales by Country (2021-2026) & (K Dose)
Table 58. Middle East & Africa Veterinary Immunization Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 60. Middle East & Africa Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 61. Key Market Drivers & Growth Opportunities of Veterinary Immunization
Table 62. Key Market Challenges & Risks of Veterinary Immunization
Table 63. Key Industry Trends of Veterinary Immunization
Table 64. Veterinary Immunization Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Veterinary Immunization Distributors List
Table 67. Veterinary Immunization Customer List
Table 68. Global Veterinary Immunization Sales Forecast by Region (2027-2032) & (K Dose)
Table 69. Global Veterinary Immunization Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Veterinary Immunization Sales Forecast by Country (2027-2032) & (K Dose)
Table 71. Americas Veterinary Immunization Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Veterinary Immunization Sales Forecast by Region (2027-2032) & (K Dose)
Table 73. APAC Veterinary Immunization Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Veterinary Immunization Sales Forecast by Country (2027-2032) & (K Dose)
Table 75. Europe Veterinary Immunization Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Veterinary Immunization Sales Forecast by Country (2027-2032) & (K Dose)
Table 77. Middle East & Africa Veterinary Immunization Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Veterinary Immunization Sales Forecast by Type (2027-2032) & (K Dose)
Table 79. Global Veterinary Immunization Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Veterinary Immunization Sales Forecast by Application (2027-2032) & (K Dose)
Table 81. Global Veterinary Immunization Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Zoetis Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Veterinary Immunization Product Portfolios and Specifications
Table 84. Zoetis Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. Merck Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 89. Merck Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Merck Animal Health Main Business
Table 91. Merck Animal Health Latest Developments
Table 92. Boehringer Ingelheim Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Boehringer Ingelheim Animal Health Main Business
Table 96. Boehringer Ingelheim Animal Health Latest Developments
Table 97. Elanco Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 98. Elanco Veterinary Immunization Product Portfolios and Specifications
Table 99. Elanco Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Elanco Main Business
Table 101. Elanco Latest Developments
Table 102. Ceva Sant? Animale Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Sant? Animale Veterinary Immunization Product Portfolios and Specifications
Table 104. Ceva Sant? Animale Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Ceva Sant? Animale Main Business
Table 106. Ceva Sant? Animale Latest Developments
Table 107. Virbac Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 108. Virbac Veterinary Immunization Product Portfolios and Specifications
Table 109. Virbac Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Virbac Main Business
Table 111. Virbac Latest Developments
Table 112. HIPRA Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 113. HIPRA Veterinary Immunization Product Portfolios and Specifications
Table 114. HIPRA Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. HIPRA Main Business
Table 116. HIPRA Latest Developments
Table 117. MSD Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 118. MSD Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 119. MSD Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. MSD Animal Health Main Business
Table 121. MSD Animal Health Latest Developments
Table 122. Phibro Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 123. Phibro Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 124. Phibro Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Phibro Animal Health Main Business
Table 126. Phibro Animal Health Latest Developments
Table 127. Vetoquinol Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 128. Vetoquinol Veterinary Immunization Product Portfolios and Specifications
Table 129. Vetoquinol Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. Vetoquinol Main Business
Table 131. Vetoquinol Latest Developments
Table 132. IDT Biologika Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 133. IDT Biologika Veterinary Immunization Product Portfolios and Specifications
Table 134. IDT Biologika Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 135. IDT Biologika Main Business
Table 136. IDT Biologika Latest Developments
Table 137. Hester Biosciences Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 138. Hester Biosciences Veterinary Immunization Product Portfolios and Specifications
Table 139. Hester Biosciences Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 140. Hester Biosciences Main Business
Table 141. Hester Biosciences Latest Developments
Table 142. Indian Immunologicals Ltd Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 143. Indian Immunologicals Ltd Veterinary Immunization Product Portfolios and Specifications
Table 144. Indian Immunologicals Ltd Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 145. Indian Immunologicals Ltd Main Business
Table 146. Indian Immunologicals Ltd Latest Developments
Table 147. Huvepharma Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 148. Huvepharma Veterinary Immunization Product Portfolios and Specifications
Table 149. Huvepharma Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 150. Huvepharma Main Business
Table 151. Huvepharma Latest Developments
Table 152. Neogen Corporation Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 153. Neogen Corporation Veterinary Immunization Product Portfolios and Specifications
Table 154. Neogen Corporation Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 155. Neogen Corporation Main Business
Table 156. Neogen Corporation Latest Developments
Table 157. BioNet?Asia Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 158. BioNet?Asia Veterinary Immunization Product Portfolios and Specifications
Table 159. BioNet?Asia Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 160. BioNet?Asia Main Business
Table 161. BioNet?Asia Latest Developments
Table 162. KBNP Inc. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 163. KBNP Inc. Veterinary Immunization Product Portfolios and Specifications
Table 164. KBNP Inc. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 165. KBNP Inc. Main Business
Table 166. KBNP Inc. Latest Developments
Table 167. Vaxxinova Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 168. Vaxxinova Veterinary Immunization Product Portfolios and Specifications
Table 169. Vaxxinova Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 170. Vaxxinova Main Business
Table 171. Vaxxinova Latest Developments
Table 172. Guangdong Haid Group Co.,Limited Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangdong Haid Group Co.,Limited Veterinary Immunization Product Portfolios and Specifications
Table 174. Guangdong Haid Group Co.,Limited Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 175. Guangdong Haid Group Co.,Limited Main Business
Table 176. Guangdong Haid Group Co.,Limited Latest Developments
Table 177. China National Medicines Corporation Ltd. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 178. China National Medicines Corporation Ltd. Veterinary Immunization Product Portfolios and Specifications
Table 179. China National Medicines Corporation Ltd. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 180. China National Medicines Corporation Ltd. Main Business
Table 181. China National Medicines Corporation Ltd. Latest Developments
Table 182. Harbin Pharmaceutical Group Co., Ltd. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 183. Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
Table 184. Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 185. Harbin Pharmaceutical Group Co., Ltd. Main Business
Table 186. Harbin Pharmaceutical Group Co., Ltd. Latest Developments
Table 187. North China Pharmaceutical Group Corporation Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 188. North China Pharmaceutical Group Corporation Veterinary Immunization Product Portfolios and Specifications
Table 189. North China Pharmaceutical Group Corporation Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 190. North China Pharmaceutical Group Corporation Main Business
Table 191. North China Pharmaceutical Group Corporation Latest Developments
Table 192. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 193. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
Table 194. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 195. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Main Business
Table 196. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Latest Developments
Table 1. Veterinary Immunization Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Veterinary Immunization Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Livestock Vaccines (pigs, cattle, sheep, etc.)
Table 4. Major Players of Poultry Vaccines (chickens, ducks, geese, etc.)
Table 5. Major Players of Companion Animal Vaccines (dogs, cats, etc.)
Table 6. Major Players of Aquaculture Vaccines (fish, shrimp, etc.)
Table 7. Global Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 8. Global Veterinary Immunization Sales Market Share by Type (2021-2026)
Table 9. Global Veterinary Immunization Revenue by Type (2021-2026) & ($ million)
Table 10. Global Veterinary Immunization Revenue Market Share by Type (2021-2026)
Table 11. Global Veterinary Immunization Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Major Players of Short-term (<3 months)
Table 13. Major Players of Medium-term (3?12 months)
Table 14. Major Players of Long-term (>12 months)
Table 15. Global Veterinary Immunization Sales by Time (2021-2026) & (K Dose)
Table 16. Global Veterinary Immunization Sales Market Share by Time (2021-2026)
Table 17. Global Veterinary Immunization Revenue by Time (2021-2026) & ($ million)
Table 18. Global Veterinary Immunization Revenue Market Share by Time (2021-2026)
Table 19. Global Veterinary Immunization Sale Price by Time (2021-2026) & (US$/Dose)
Table 20. Global Veterinary Immunization Sale by Application (2021-2026) & (K Dose)
Table 21. Global Veterinary Immunization Sale Market Share by Application (2021-2026)
Table 22. Global Veterinary Immunization Revenue by Application (2021-2026) & ($ million)
Table 23. Global Veterinary Immunization Revenue Market Share by Application (2021-2026)
Table 24. Global Veterinary Immunization Sale Price by Application (2021-2026) & (US$/Dose)
Table 25. Global Veterinary Immunization Sales by Company (2021-2026) & (K Dose)
Table 26. Global Veterinary Immunization Sales Market Share by Company (2021-2026)
Table 27. Global Veterinary Immunization Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Veterinary Immunization Revenue Market Share by Company (2021-2026)
Table 29. Global Veterinary Immunization Sale Price by Company (2021-2026) & (US$/Dose)
Table 30. Key Manufacturers Veterinary Immunization Producing Area Distribution and Sales Area
Table 31. Players Veterinary Immunization Products Offered
Table 32. Veterinary Immunization Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Veterinary Immunization Sales by Geographic Region (2021-2026) & (K Dose)
Table 36. Global Veterinary Immunization Sales Market Share Geographic Region (2021-2026)
Table 37. Global Veterinary Immunization Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Veterinary Immunization Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Veterinary Immunization Sales by Country/Region (2021-2026) & (K Dose)
Table 40. Global Veterinary Immunization Sales Market Share by Country/Region (2021-2026)
Table 41. Global Veterinary Immunization Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Veterinary Immunization Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Veterinary Immunization Sales by Country (2021-2026) & (K Dose)
Table 44. Americas Veterinary Immunization Sales Market Share by Country (2021-2026)
Table 45. Americas Veterinary Immunization Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 47. Americas Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 48. APAC Veterinary Immunization Sales by Region (2021-2026) & (K Dose)
Table 49. APAC Veterinary Immunization Sales Market Share by Region (2021-2026)
Table 50. APAC Veterinary Immunization Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 52. APAC Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 53. Europe Veterinary Immunization Sales by Country (2021-2026) & (K Dose)
Table 54. Europe Veterinary Immunization Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 56. Europe Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 57. Middle East & Africa Veterinary Immunization Sales by Country (2021-2026) & (K Dose)
Table 58. Middle East & Africa Veterinary Immunization Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Veterinary Immunization Sales by Type (2021-2026) & (K Dose)
Table 60. Middle East & Africa Veterinary Immunization Sales by Application (2021-2026) & (K Dose)
Table 61. Key Market Drivers & Growth Opportunities of Veterinary Immunization
Table 62. Key Market Challenges & Risks of Veterinary Immunization
Table 63. Key Industry Trends of Veterinary Immunization
Table 64. Veterinary Immunization Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Veterinary Immunization Distributors List
Table 67. Veterinary Immunization Customer List
Table 68. Global Veterinary Immunization Sales Forecast by Region (2027-2032) & (K Dose)
Table 69. Global Veterinary Immunization Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Veterinary Immunization Sales Forecast by Country (2027-2032) & (K Dose)
Table 71. Americas Veterinary Immunization Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Veterinary Immunization Sales Forecast by Region (2027-2032) & (K Dose)
Table 73. APAC Veterinary Immunization Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Veterinary Immunization Sales Forecast by Country (2027-2032) & (K Dose)
Table 75. Europe Veterinary Immunization Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Veterinary Immunization Sales Forecast by Country (2027-2032) & (K Dose)
Table 77. Middle East & Africa Veterinary Immunization Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Veterinary Immunization Sales Forecast by Type (2027-2032) & (K Dose)
Table 79. Global Veterinary Immunization Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Veterinary Immunization Sales Forecast by Application (2027-2032) & (K Dose)
Table 81. Global Veterinary Immunization Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Zoetis Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Veterinary Immunization Product Portfolios and Specifications
Table 84. Zoetis Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. Merck Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 89. Merck Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Merck Animal Health Main Business
Table 91. Merck Animal Health Latest Developments
Table 92. Boehringer Ingelheim Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Boehringer Ingelheim Animal Health Main Business
Table 96. Boehringer Ingelheim Animal Health Latest Developments
Table 97. Elanco Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 98. Elanco Veterinary Immunization Product Portfolios and Specifications
Table 99. Elanco Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Elanco Main Business
Table 101. Elanco Latest Developments
Table 102. Ceva Sant? Animale Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Sant? Animale Veterinary Immunization Product Portfolios and Specifications
Table 104. Ceva Sant? Animale Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Ceva Sant? Animale Main Business
Table 106. Ceva Sant? Animale Latest Developments
Table 107. Virbac Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 108. Virbac Veterinary Immunization Product Portfolios and Specifications
Table 109. Virbac Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Virbac Main Business
Table 111. Virbac Latest Developments
Table 112. HIPRA Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 113. HIPRA Veterinary Immunization Product Portfolios and Specifications
Table 114. HIPRA Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. HIPRA Main Business
Table 116. HIPRA Latest Developments
Table 117. MSD Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 118. MSD Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 119. MSD Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. MSD Animal Health Main Business
Table 121. MSD Animal Health Latest Developments
Table 122. Phibro Animal Health Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 123. Phibro Animal Health Veterinary Immunization Product Portfolios and Specifications
Table 124. Phibro Animal Health Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Phibro Animal Health Main Business
Table 126. Phibro Animal Health Latest Developments
Table 127. Vetoquinol Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 128. Vetoquinol Veterinary Immunization Product Portfolios and Specifications
Table 129. Vetoquinol Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 130. Vetoquinol Main Business
Table 131. Vetoquinol Latest Developments
Table 132. IDT Biologika Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 133. IDT Biologika Veterinary Immunization Product Portfolios and Specifications
Table 134. IDT Biologika Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 135. IDT Biologika Main Business
Table 136. IDT Biologika Latest Developments
Table 137. Hester Biosciences Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 138. Hester Biosciences Veterinary Immunization Product Portfolios and Specifications
Table 139. Hester Biosciences Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 140. Hester Biosciences Main Business
Table 141. Hester Biosciences Latest Developments
Table 142. Indian Immunologicals Ltd Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 143. Indian Immunologicals Ltd Veterinary Immunization Product Portfolios and Specifications
Table 144. Indian Immunologicals Ltd Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 145. Indian Immunologicals Ltd Main Business
Table 146. Indian Immunologicals Ltd Latest Developments
Table 147. Huvepharma Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 148. Huvepharma Veterinary Immunization Product Portfolios and Specifications
Table 149. Huvepharma Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 150. Huvepharma Main Business
Table 151. Huvepharma Latest Developments
Table 152. Neogen Corporation Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 153. Neogen Corporation Veterinary Immunization Product Portfolios and Specifications
Table 154. Neogen Corporation Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 155. Neogen Corporation Main Business
Table 156. Neogen Corporation Latest Developments
Table 157. BioNet?Asia Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 158. BioNet?Asia Veterinary Immunization Product Portfolios and Specifications
Table 159. BioNet?Asia Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 160. BioNet?Asia Main Business
Table 161. BioNet?Asia Latest Developments
Table 162. KBNP Inc. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 163. KBNP Inc. Veterinary Immunization Product Portfolios and Specifications
Table 164. KBNP Inc. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 165. KBNP Inc. Main Business
Table 166. KBNP Inc. Latest Developments
Table 167. Vaxxinova Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 168. Vaxxinova Veterinary Immunization Product Portfolios and Specifications
Table 169. Vaxxinova Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 170. Vaxxinova Main Business
Table 171. Vaxxinova Latest Developments
Table 172. Guangdong Haid Group Co.,Limited Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangdong Haid Group Co.,Limited Veterinary Immunization Product Portfolios and Specifications
Table 174. Guangdong Haid Group Co.,Limited Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 175. Guangdong Haid Group Co.,Limited Main Business
Table 176. Guangdong Haid Group Co.,Limited Latest Developments
Table 177. China National Medicines Corporation Ltd. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 178. China National Medicines Corporation Ltd. Veterinary Immunization Product Portfolios and Specifications
Table 179. China National Medicines Corporation Ltd. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 180. China National Medicines Corporation Ltd. Main Business
Table 181. China National Medicines Corporation Ltd. Latest Developments
Table 182. Harbin Pharmaceutical Group Co., Ltd. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 183. Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
Table 184. Harbin Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 185. Harbin Pharmaceutical Group Co., Ltd. Main Business
Table 186. Harbin Pharmaceutical Group Co., Ltd. Latest Developments
Table 187. North China Pharmaceutical Group Corporation Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 188. North China Pharmaceutical Group Corporation Veterinary Immunization Product Portfolios and Specifications
Table 189. North China Pharmaceutical Group Corporation Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 190. North China Pharmaceutical Group Corporation Main Business
Table 191. North China Pharmaceutical Group Corporation Latest Developments
Table 192. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Basic Information, Veterinary Immunization Manufacturing Base, Sales Area and Its Competitors
Table 193. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Product Portfolios and Specifications
Table 194. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Veterinary Immunization Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 195. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Main Business
Table 196. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Immunization
Figure 2. Veterinary Immunization Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Immunization Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Veterinary Immunization Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Immunization Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Immunization Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Immunization Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Livestock Vaccines (pigs, cattle, sheep, etc.)
Figure 12. Product Picture of Poultry Vaccines (chickens, ducks, geese, etc.)
Figure 13. Product Picture of Companion Animal Vaccines (dogs, cats, etc.)
Figure 14. Product Picture of Aquaculture Vaccines (fish, shrimp, etc.)
Figure 15. Global Veterinary Immunization Sales Market Share by Type in 2026
Figure 16. Global Veterinary Immunization Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Short-term (<3 months)
Figure 18. Product Picture of Medium-term (3?12 months)
Figure 19. Product Picture of Long-term (>12 months)
Figure 20. Global Veterinary Immunization Sales Market Share by Time in 2026
Figure 21. Global Veterinary Immunization Revenue Market Share by Time (2021-2026)
Figure 22. Veterinary Immunization Consumed in Livestock Farms
Figure 23. Global Veterinary Immunization Market: Livestock Farms (2021-2026) & (K Dose)
Figure 24. Veterinary Immunization Consumed in Poultry Farms
Figure 25. Global Veterinary Immunization Market: Poultry Farms (2021-2026) & (K Dose)
Figure 26. Veterinary Immunization Consumed in Pet Clinics
Figure 27. Global Veterinary Immunization Market: Pet Clinics (2021-2026) & (K Dose)
Figure 28. Veterinary Immunization Consumed in Aquaculture Farms
Figure 29. Global Veterinary Immunization Market: Aquaculture Farms (2021-2026) & (K Dose)
Figure 30. Veterinary Immunization Consumed in Government Disease Control Agencies
Figure 31. Global Veterinary Immunization Market: Government Disease Control Agencies (2021-2026) & (K Dose)
Figure 32. Veterinary Immunization Consumed in Other
Figure 33. Global Veterinary Immunization Market: Other (2021-2026) & (K Dose)
Figure 34. Global Veterinary Immunization Sale Market Share by Application (2025)
Figure 35. Global Veterinary Immunization Revenue Market Share by Application in 2025
Figure 36. Veterinary Immunization Sales by Company in 2025 (K Dose)
Figure 37. Global Veterinary Immunization Sales Market Share by Company in 2025
Figure 38. Veterinary Immunization Revenue by Company in 2025 ($ millions)
Figure 39. Global Veterinary Immunization Revenue Market Share by Company in 2025
Figure 40. Global Veterinary Immunization Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Veterinary Immunization Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 43. Americas Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 44. APAC Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 45. APAC Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 46. Europe Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 47. Europe Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 49. Middle East & Africa Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 50. Americas Veterinary Immunization Sales Market Share by Country in 2025
Figure 51. Americas Veterinary Immunization Revenue Market Share by Country (2021-2026)
Figure 52. Americas Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 53. Americas Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 54. United States Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Veterinary Immunization Sales Market Share by Region in 2025
Figure 59. APAC Veterinary Immunization Revenue Market Share by Region (2021-2026)
Figure 60. APAC Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 61. APAC Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 62. China Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 66. India Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Veterinary Immunization Sales Market Share by Country in 2025
Figure 70. Europe Veterinary Immunization Revenue Market Share by Country (2021-2026)
Figure 71. Europe Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 72. Europe Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 73. Germany Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 74. France Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Veterinary Immunization Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 81. Egypt Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Veterinary Immunization in 2026
Figure 87. Manufacturing Process Analysis of Veterinary Immunization
Figure 88. Industry Chain Structure of Veterinary Immunization
Figure 89. Channels of Distribution
Figure 90. Global Veterinary Immunization Sales Market Forecast by Region (2027-2032)
Figure 91. Global Veterinary Immunization Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Veterinary Immunization Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Veterinary Immunization Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Veterinary Immunization Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Veterinary Immunization Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Veterinary Immunization
Figure 2. Veterinary Immunization Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Immunization Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Veterinary Immunization Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Veterinary Immunization Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Veterinary Immunization Sales Market Share by Country/Region (2025)
Figure 10. Veterinary Immunization Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Livestock Vaccines (pigs, cattle, sheep, etc.)
Figure 12. Product Picture of Poultry Vaccines (chickens, ducks, geese, etc.)
Figure 13. Product Picture of Companion Animal Vaccines (dogs, cats, etc.)
Figure 14. Product Picture of Aquaculture Vaccines (fish, shrimp, etc.)
Figure 15. Global Veterinary Immunization Sales Market Share by Type in 2026
Figure 16. Global Veterinary Immunization Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Short-term (<3 months)
Figure 18. Product Picture of Medium-term (3?12 months)
Figure 19. Product Picture of Long-term (>12 months)
Figure 20. Global Veterinary Immunization Sales Market Share by Time in 2026
Figure 21. Global Veterinary Immunization Revenue Market Share by Time (2021-2026)
Figure 22. Veterinary Immunization Consumed in Livestock Farms
Figure 23. Global Veterinary Immunization Market: Livestock Farms (2021-2026) & (K Dose)
Figure 24. Veterinary Immunization Consumed in Poultry Farms
Figure 25. Global Veterinary Immunization Market: Poultry Farms (2021-2026) & (K Dose)
Figure 26. Veterinary Immunization Consumed in Pet Clinics
Figure 27. Global Veterinary Immunization Market: Pet Clinics (2021-2026) & (K Dose)
Figure 28. Veterinary Immunization Consumed in Aquaculture Farms
Figure 29. Global Veterinary Immunization Market: Aquaculture Farms (2021-2026) & (K Dose)
Figure 30. Veterinary Immunization Consumed in Government Disease Control Agencies
Figure 31. Global Veterinary Immunization Market: Government Disease Control Agencies (2021-2026) & (K Dose)
Figure 32. Veterinary Immunization Consumed in Other
Figure 33. Global Veterinary Immunization Market: Other (2021-2026) & (K Dose)
Figure 34. Global Veterinary Immunization Sale Market Share by Application (2025)
Figure 35. Global Veterinary Immunization Revenue Market Share by Application in 2025
Figure 36. Veterinary Immunization Sales by Company in 2025 (K Dose)
Figure 37. Global Veterinary Immunization Sales Market Share by Company in 2025
Figure 38. Veterinary Immunization Revenue by Company in 2025 ($ millions)
Figure 39. Global Veterinary Immunization Revenue Market Share by Company in 2025
Figure 40. Global Veterinary Immunization Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Veterinary Immunization Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 43. Americas Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 44. APAC Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 45. APAC Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 46. Europe Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 47. Europe Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Veterinary Immunization Sales 2021-2026 (K Dose)
Figure 49. Middle East & Africa Veterinary Immunization Revenue 2021-2026 ($ millions)
Figure 50. Americas Veterinary Immunization Sales Market Share by Country in 2025
Figure 51. Americas Veterinary Immunization Revenue Market Share by Country (2021-2026)
Figure 52. Americas Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 53. Americas Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 54. United States Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Veterinary Immunization Sales Market Share by Region in 2025
Figure 59. APAC Veterinary Immunization Revenue Market Share by Region (2021-2026)
Figure 60. APAC Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 61. APAC Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 62. China Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 66. India Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Veterinary Immunization Sales Market Share by Country in 2025
Figure 70. Europe Veterinary Immunization Revenue Market Share by Country (2021-2026)
Figure 71. Europe Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 72. Europe Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 73. Germany Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 74. France Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Veterinary Immunization Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Veterinary Immunization Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Veterinary Immunization Sales Market Share by Application (2021-2026)
Figure 81. Egypt Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Veterinary Immunization Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Veterinary Immunization in 2026
Figure 87. Manufacturing Process Analysis of Veterinary Immunization
Figure 88. Industry Chain Structure of Veterinary Immunization
Figure 89. Channels of Distribution
Figure 90. Global Veterinary Immunization Sales Market Forecast by Region (2027-2032)
Figure 91. Global Veterinary Immunization Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Veterinary Immunization Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Veterinary Immunization Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Veterinary Immunization Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Veterinary Immunization Revenue Market Share Forecast by Application (2027-2032)
